Stock Code


Shanghai, China – Recently, results of Shanghai Intellectual Property Innovation Award were released. This activity was carried out jointly by Shanghai Municipal Bureau of human resources and social security, Shanghai Intellectual Property Administration. A patent named Stent-Graft System and its usage of Hercules™ Low-Profile Thoracic Stent-Graft System(“Hercules™-LP”),which belongs to Shanghai MicroPort Endovascular MedTech Co., Ltd (“Endovasctec™”), won second prize of patent and trademark in the Shanghai Intellectual Property Innovation Award with its cultivation, transformation and industrialization of high-value intellectual property. Endovasctec™ was awarded the Shanghai Patent Work Pilot Enterprise in 2017.

Hercules™-LP is an upgrade to the Hercules™ Thoracic Stent-Graft System, which is used primarily for the interventional treatment of thoracic aortic aneurysms. This product makes the positioning and release of the stent graft more precise and stable through the bare stent release mechanism. It is one of the earliest thoracic aortic stent products with the outer sheath diameter of the delivery system in the domestic market, the first thoracic aortic aneurysm ("TAA") stent to have low profile delivery system with 18F outer diameter, which can benefit more patients. In addition, its soft inner sleeves are made of PET, which makes it easier for the stent to cross the aortic arch. Its stent has a large taper design with a taper of 0-10mm, which is more consistent with the pathological characteristics of aortic dissection. And its main body section becomes higher, which improves the overall flexibility of the stent. Hercules™-LP enables effective treatment of thoracic aortic disease and facilitate physicians to cope with the challenges in clinical treatment.


Shanghai Intellectual Property Innovation Awards are designed to recognize individuals and institutions that have demonstrated outstanding achievements in the creation, protection, and application of intellectual property in the city, as well as individuals or organizations that have made outstanding contributions to intellectual property innovation and creative activities. Its establishment not only accelerates the construction of Shanghai's intellectual property center cities in the Asia-Pacific region, but also gives full play to the support and guarantee role of intellectual property rights to promote the construction of a globally influential science and technology innovation center in Shanghai.

It will also promote Shanghai enterprises to become more international and high-end in the intellectual property work. This award is a full affirmation of the relevant departments of the Shanghai Municipal Government for our long-term efforts in the creation and management of intellectual property innovation. Endovasctec™ always takes product development and innovation as its core competitiveness, and continuously develops a series of high-tech products independently. Meanwhile, it attaches great importance to intellectual property protection, laying a solid foundation for the company's rapid advancement. In the future, Endovasctec™ will continue to innovate, further incubating core patent technologies with innovation and practicality, promoting the industrialization of scientific and technological achievements and intellectual property, and then driving the company's industry to high-end development of global value, finally promoting the faster development of innovation in China's medical device enterprises.